← Back to Search

Connect2Test for Coronavirus Pandemic

N/A

Waitlist Available

Research Sponsored by University of Oregon

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 9-months after intervention

Awards & highlights

Study Summary

This trial will compare the effectiveness of two different approaches to increasing SARS-CoV-2 testing and vaccination uptake among people who inject drugs (PWIDs). The first approach is contingency management (CM), which uses rewards to motivate behavior change. The second approach is CM plus a brief motivational enhancement intervention (MEI). The goal of this trial is to reduce COVID-19 health disparities among PWIDs and to decrease population level COVID-19 morbidity and mortality.

Eligible Conditions

Coronavirus Pandemic

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 9-months after intervention

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 9-months after intervention

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 9-months after intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

SARS-CoV-2 Testing

Secondary outcome measures

Vaccination

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Connect2Test Intervention + Contingency ManagementExperimental Treatment1 Intervention

$10 financial incentive for vaccination and $10 financial incentive for testing plus a brief feedback-based motivational enhancement intervention.

Group II: Contingency Management AloneActive Control1 Intervention

$10 financial incentive for vaccination and $10 financial incentive for testing.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Connect2Test

2022

N/A

~350

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of OregonLead Sponsor

80 Previous Clinical Trials

46,410 Total Patients Enrolled

National Institute on Drug Abuse (NIDA)NIH

2,464 Previous Clinical Trials

2,618,244 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the total sample size for this investigation?

"Accurate. Clinicaltrials.gov attests that this clinical trial was first posted on August 8th 2022 and is actively seeking participants as of October 31st, 2022. The investigators need to include 350 individuals from a single location in the study."

Answered by AI

Are there any available slots for participants in this trial?

"According to the information provided on clinicaltrials.gov, recruitment for this trial is ongoing; it was initially announced on August 8th 2022 and modified most recently on October 31st 2022."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Motivation, Syringe Exchange, and COVID-19

2022. "Motivation, Syringe Exchange, and COVID-19". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05534061.